Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer.
Seidman AD, Hochhauser D, Gollub M, Edelman B, Yao TJ, Hudis CA, Francis P, Fennelly D, Gilewski TA, Moynahan ME, Currie V, Baselga J, Tong W, O'Donaghue M, Salvaggio R, Auguste L, Spriggs D, Norton L.
Seidman AD, et al.
J Clin Oncol. 1996 Jun;14(6):1877-84. doi: 10.1200/JCO.1996.14.6.1877.
J Clin Oncol. 1996.
PMID: 8656256
Clinical Trial.